Rein Therapeutics Inc. (RNTX)
Market Open
11 Sep, 14:53
NASDAQ (CM) NASDAQ (CM) Primary $
0. 79
+0.01
+1.319%
$
24.86M Market Cap
- P/E Ratio
- Div Yield
34,878 Volume
- Eps
$ 0.78
Previous Close 
Want to track RNTX and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Here's Why You Should Add RNTX Stock to Your Portfolio Now
Rein Therapeutics advances LTI-03 in IPF. RENEW enrollment tops 25%, with interim data expected in the fourth quarter of 2026.
Zacks | 1 week ago
All You Need to Know About Rein Therapeutics Inc. (RNTX) Rating Upgrade to Buy
Rein Therapeutics Inc. (RNTX) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Zacks | 2 months ago
Rein Therapeutics (NASDAQ:RNTX) Stock Price Up 1.6% – What’s Next?
Shares of Rein Therapeutics Inc. (NASDAQ: RNTX - Get Free Report) traded up 1.6% during trading on Friday. The stock traded as high as $1.3451 and last traded at $1.30. 44,298 shares changed hands during trading, a decline of 51% from the average session volume of 90,560 shares. The stock had previously closed at $1.28.
Defenseworld | 6 months ago
